ArticleAmerican journal of public health2023
Identifying COVID-19 Vaccine Deserts and Ways to Reduce Them: A Digital Tool to Support Public Health Decision-Making.
Abstract read
In one paragraph
Article in American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Extreme geographic misalignment of healthcare resources and HIV treatment deserts in Malawi.Nature medicine · 2025Article
- Spatial Accessibility and Uptake of Pediatric COVID-19 Vaccinations by Social Vulnerability.Pediatrics · 2024Article
- Measuring vaccination coverage and concerns of vaccine holdouts from web search logs.Nature communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Rebecca L WeintraubAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Kate MillerAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Benjamin RaderAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Julie RosenbergAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Shreyas SrinathAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Samuel R WoodburyAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Marinanicole D SchultheissAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Mansi KansalAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Swapnil VisputeAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Stylianos SerghiouAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Gerardo FloresAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Akim KumokAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Tomer ShekelAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Evgeniy GabrilovichAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Iman AhmadAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Molly E ChiangAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
John S BrownsteinAt the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston Children's Hospital, Boston. Mansi Kansal, Swapnil Vispute, Stylianos Serghiou, Gerardo Flores, Akim Kumok, Tomer Shekel, and Evgeniy Gabrilovich were with Google Inc, Mountain View, CA.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A private-academic partnership built the Vaccine Equity Planner (VEP) to help decision-makers improve geographic access to COVID-19 vaccinations across the United States by identifying vaccine deserts and facilities that could fill those deserts. The VEP presented complex, updated data in an intuitive form during a rapidly changing pandemic situation. The persistence of vaccine deserts in every state as COVID-19 booster recommendations develop suggests that vaccine delivery can be improved. Underresourced public health systems benefit from tools providing real-time, accurate, actionable data. (
Indexed as
COVID-19COVID-19 VaccinesHumansMedical AssistancePandemicsPublic HealthCOVID-19 Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.